Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01ENR
|
|||
| Former ID |
DNC005184
|
|||
| Drug Name |
4-[2-(2-Benzyl-phenoxy)-ethyl]-morpholine
|
|||
| Synonyms |
CHEMBL365697; 4-[2-(2-benzylphenoxy)ethyl]morpholine; AC1MGXJ0; 4-[2-(2-Benzyl-phenoxy)-ethyl]-morpholine; BDBM50151042
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H23NO2
|
|||
| Canonical SMILES |
C1COCCN1CCOC2=CC=CC=C2CC3=CC=CC=C3
|
|||
| InChI |
1S/C19H23NO2/c1-2-6-17(7-3-1)16-18-8-4-5-9-19(18)22-15-12-20-10-13-21-14-11-20/h1-9H,10-16H2
|
|||
| InChIKey |
DQESEABEPUDVEZ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Dopamine/serotonin receptor ligands. 9. Oxygen-containing midsized heterocyclic ring systems and nonrigidized analogues. A step toward dopamine D5 ... J Med Chem. 2004 Aug 12;47(17):4155-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.